ATE307829T1 - Skorpion-spezifische neuropeptide - Google Patents

Skorpion-spezifische neuropeptide

Info

Publication number
ATE307829T1
ATE307829T1 AT97950385T AT97950385T ATE307829T1 AT E307829 T1 ATE307829 T1 AT E307829T1 AT 97950385 T AT97950385 T AT 97950385T AT 97950385 T AT97950385 T AT 97950385T AT E307829 T1 ATE307829 T1 AT E307829T1
Authority
AT
Austria
Prior art keywords
cys
lys
arg
pro
scorpion
Prior art date
Application number
AT97950385T
Other languages
English (en)
Inventor
Bruno Lebrun
Regine Romi-Lebrun
Hiroyuki Minakata
Terumi Nakajima
Junko Hashino
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ATE307829T1 publication Critical patent/ATE307829T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43522—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from scorpions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97950385T 1996-12-26 1997-12-25 Skorpion-spezifische neuropeptide ATE307829T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP35981596 1996-12-26
JP31287197 1997-10-30
PCT/JP1997/004810 WO1998029446A1 (fr) 1996-12-26 1997-12-25 Neuropeptides provenant du scorpion

Publications (1)

Publication Number Publication Date
ATE307829T1 true ATE307829T1 (de) 2005-11-15

Family

ID=26567350

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97950385T ATE307829T1 (de) 1996-12-26 1997-12-25 Skorpion-spezifische neuropeptide

Country Status (8)

Country Link
US (1) US6689749B1 (de)
EP (1) EP0916681B1 (de)
JP (1) JP4212651B2 (de)
AT (1) ATE307829T1 (de)
CA (1) CA2247328C (de)
DE (1) DE69734451T2 (de)
ES (1) ES2247642T3 (de)
WO (1) WO1998029446A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2266746C2 (ru) * 2004-03-12 2005-12-27 Закрытое Акционерное Общество "Лорр" Средство для лечения невралгических заболеваний
US7833979B2 (en) * 2005-04-22 2010-11-16 Amgen Inc. Toxin peptide therapeutic agents
WO2007137163A2 (en) 2006-05-19 2007-11-29 Georgia Tech Research Corporation Abc transporter ligand
US8324158B2 (en) * 2006-07-14 2012-12-04 Georgia Tech Research Corporation Methods for inhibiting CLC-2 channel with GATX2
PE20081140A1 (es) * 2006-10-25 2008-09-22 Amgen Inc Agentes terapeuticos a base de peptidos derivados de toxinas
CA2686216C (en) * 2007-05-14 2016-04-12 Universidad Nacional Autonoma De Mexico Vm23 and vm24, two scorpion peptides that block human t-lymphocyte potassium channels (sub-type kv1.3) with high selectivity and decrease the in vivo dth-responses in rats
JP5591691B2 (ja) 2007-05-22 2014-09-17 アムジエン・インコーポレーテツド 生物活性を有する融合タンパク質を作製するための組成物及び方法
WO2010108154A2 (en) 2009-03-20 2010-09-23 Amgen Inc. Selective and potent peptide inhibitors of kv1.3
CN103339145A (zh) 2010-09-22 2013-10-02 安姆根有限公司 运载体免疫球蛋白及其用途
SG10201601789TA (en) 2011-03-16 2016-04-28 Amgen Inc Potent And Selective Inhibitors Of Nav1.3 And Nav1.7
US10344060B2 (en) 2013-03-12 2019-07-09 Amgen Inc. Potent and selective inhibitors of Nav1.7
US9708377B2 (en) 2013-10-28 2017-07-18 Monash University Scorpion toxin analogue and method for treating autoimmune diseases
US10668113B2 (en) 2017-03-31 2020-06-02 Vivekananda Ramana Formulation for targeting cancer in humans and canines using venom
US10668112B2 (en) 2017-03-31 2020-06-02 Vivekananda Ramana Formulation for targeting cancer in humans and canines
US10668130B2 (en) 2017-03-31 2020-06-02 Vivekananda Ramana Formulation for targeting cancer in humans and canines using chlorotoxin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5494895A (en) * 1993-07-22 1996-02-27 Merck & Co., Inc. Scorpion peptide margatoxin with immunosuppressant activity

Also Published As

Publication number Publication date
EP0916681A1 (de) 1999-05-19
US6689749B1 (en) 2004-02-10
ES2247642T3 (es) 2006-03-01
CA2247328A1 (en) 1998-07-09
EP0916681A4 (de) 2003-01-02
CA2247328C (en) 2007-01-30
EP0916681B1 (de) 2005-10-26
DE69734451D1 (de) 2005-12-01
DE69734451T2 (de) 2006-07-13
WO1998029446A1 (fr) 1998-07-09
JP4212651B2 (ja) 2009-01-21

Similar Documents

Publication Publication Date Title
DE69734451D1 (de) Skorpion-spezifische neuropeptide
Loret et al. An anti-insect toxin purified from the scorpion Androctonus australis Hector also acts on the. alpha.-and. beta.-sites of the mammalian sodium channel: sequence and circular dichroism study
Kini et al. A hypothetical structural role for proline residues in the flanking segments of protein-protein interaction sites
PT847278E (pt) Analogos de hormona paratiroide
EP0871654A4 (de) Protegrine
DE68916932D1 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
DE69735580D1 (de) An aminosaeure angereicherte speicherproteine, insbesondere an lysin angereicherte mais-gamma-zeine, und diese exprimierende pflanzen
BR9007921A (pt) Sequencia de dna codificando para um derivado de fator viii humano,recombinante biologicamente ativo,vetor de expressao recombinante,cellula haspedeira de origem animal,processo para a fabricacao de um derivado e derivado de fator viii humano
AR036196A1 (es) Agentes de contraste multimericos dirigidos a base de peptidos
PT711305E (pt) Protegrinas
BR9306272A (pt) Peptídeo e composiçao farmacêutica
DE68927379D1 (de) Plättchen blockierende peptide
KR950702577A (ko) 아젤레높시스 아페르타(agelenopsis aperta)로 부터의 칼슘 채널 차단 폴리펩티드(calcium channel blocking polypeptide from agelenopsis aperta)
ATE270305T1 (de) Peptide des antisekretorischen faktors, welches krankhafte permeabilitätsanderungen reguliert
FI930626A0 (fi) Proteinstruktur hos vaexttoxingelonin
CA2137280A1 (fr) Clonage du gene codant pour la proteine gp28.5 de toxoplasma gondii; fragments peptidiques de cette proteine et leurs applications
EP1117682A4 (de) Peptide
Aird et al. Amino acid sequence of the basic subunit of Mojave toxin from the venom of the Mojave rattlesnake (Crotalus s. scutulatus)
Nair et al. STRUCTURAL CHARACTERISTICS OF PROLYL RESIDUES—A REVIEW.
NO20002001L (no) Peptider i stand til Õ inhibere interaksjonen mellom preseniliner og <beta>-amyloidpeptidet eller dettes forløper
Tonoike et al. Primary structure of the variable region of an amyloidogenic Bence Jones protein NIG-77
WO1997041220B1 (fr) Peptides derives du facteur von willebrand et leur utilisation comme anticoagulant
PT833919E (pt) Toxina botulinica do tipo f e sua utilizacao
Chen et al. Primary structure of the L chain from a rabbit homogeneous antibody to streptococcal carbohydrate. II. Sequence determination of peptides from tryptic and peptic digests.
DE68905097D1 (de) Peptid-molekuele, wirksam gegen gram-positive keime.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties